Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: • Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; • The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; • The current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows including without any limitation, any supply chain and logistics issues • Our ability to achieve the strategic and other objectives relating to the acquisition of Clariant’s Masterbatch business, including any expected synergies; • Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; • Fluctuations in raw material prices, quality and supply, and in energy prices and supply; • Production outages or material costs associated with scheduled or unscheduled maintenance programs; • Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; • An inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals; • Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; • Information systems failures and cyberattacks; • Our ability to consummate and successfully integrate acquisitions; • Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; and • Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2020 under Item 1A, “Risk Factors.” The Company does not provide reconciliations of forward-looking non-GAAP financial measures, such as outlook for Adjusted EBITDA, Adjusted Earnings Per Share, Adjusted Operating Income and Free Cash Flow, to the most comparable GAAP financial measures on a forward-looking basis because the Company is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 81% Median: 78% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $580M and excludes one-time synergy capture CAPEX ($20M) 87 90 86 82 80 78 73 87 82 82 79 79 78 78 77 76 71 67 46 en t (6) Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the median of other selected chemical / specialty companies.

Payments that may be subject to backup withholding include interest, tax-exempt interest, dividends, broker and barter exchange transactions, rents, royalties, nonemployee pay, payments made in settlement of payment card and third party network transactions, and certain payments from fishing boat operators. Corporations are not exempt from backup withholding for payments made in settlement of payment card or third party network transactions Other payments” include payments made in the course of the requester’s trade or business for rents, royalties, goods (other than bills for merchandise), medical and health care services (including payments to corporations), payments to a nonemployee for services, payments made in settlement of payment card and third party network transactions, payments to certain fishing boat crew members and fishermen, and gross proceeds paid to attorneys (including payments to corporations). 5.

Power Tool, Reworked. Compartment Cover for Medical Device

HEALTHCARE DEVICE OEM C O N T I N U O U S G L U C O S E M O N I T O R • Specific color matching for brand alignment and recognition • Chemically resistant material to help product last longer • Single source for materials and color expertise • Provided a pre-colored solution that met rigorous application requirements to improve color consistency between products • Incorporated scratch & mar resistant additives for improved durability • Offered the ability to run small pilot lots • Met regulatory requirements for USP Class VI Trilliant™ HC Thermoplastics KEY REQUIREMENTS WHY AVIENT?

AVIENT SOLUTION MEDICAL DEVICE MANUFACTURER C O M P A R T M E N T C O V E R • Improve grip with a matte rubber finish • Comply with RoHS Directive • Provide superior adhesion to PC/ABS • Achieved excellent adhesion to PC/ABS at a lower wall thickness of to 2mm • Improved aesthetics and usability with the rubber finish provided by our custom formulation • Provided quick responses to customer queries and accelerated time to market KEY REQUIREMENTS GOOD ADHESION + COMPLIANCE LEARN MORE Versollan™ Thermoplastic Elastomers Copyright © 2023, Avient Corporation.

SURGICAL DEVICE MANUFACTURER H A N D L E H O U S I N G F O R L A P A R O S C O P I C S E A L E R • Excellent adhesion onto PC/ABS • Good aesthetics with soft touch • RoHS, REACH and FDA compliant • Enhanced ergonomics and functionality with improved soft grip • Met performance requirements for wear resistance and colorability • Customized a thermoplastic elastomer (TPE) solution and had with a faster sample response speed than competitor Versaflex™ Overmolding Formulation KEY REQUIREMENTS WHY AVIENT?

CONTINUOUS GLUCOSE MONITORING OEM C G M S Y S T E M M O N I T O R • Provide color options that work within a limited existing pigment set • Offer regulatory support in achieving approval for new color formulations • Shorten development time to gain faster approvals and realize lower costs • Offered color options that met desired aesthetics and moods utilizing the approved pigment set while creating a distinct color difference from an existing device • Provided support in achieving regulatory approvals, resulting in significant cost and time savings • Compressed the timeline through on-site color visualization, exploration, and formulation of new colors ColorWorks™ Design Center, Phoenix, AZ KEY REQUIREMENTS WHY AVIENT?

AVIENT SOLUTION LIGHTWEIGHTING + CYCLE TIME LEARN MORE • Achieved average weight reduction across molds of 7.75% • Achieved cycle time reduction of 15-20% • Provided key support with equipment and processing • Reduced energy consumption • Projected savings of $500,000 annually KEY REQUIREMENTS • Lightweighting • Cycle time improvement • Processing support to enable a seamless transition to begin using foam Copyright © 2020, Avient Corporation.

Solutions to help reduce carbon footprint by lightweighting using recycled materials in injection molded and extruded applications for automotive and consumer goods industries, such as Hydrocerol™ Chemical Foaming Agents developed to reduce material consumption, part weight, and cycle times while maintaining excellent surface finish and eliminating sink marks, and can also serve as nucleating additives in direct gassing foam extrusion processes  Versaflex™ TPEs: can reduce vibration in consumer goods such as household appliances and power tools by up to 80% compared to traditional thermoplastic vulcanizates (TPVs)

Our systems, networks and products may be vulnerable to advanced persistent threats or other types of system failures. Vice President and General Manager, Power Coatings, Valspar Corporation from February 2002 to June 2007. The fair value of the trade names is calculated using a “relief from royalty” methodology.